(1R,3R)-3-Benzoic acid 3-carboxycyclopentyl ester |
A synthetic intermediate useful for pharmaceutical synthesis. |
50 mg |
11366-50 |
More Info
|
13(R),14(R)-epoxy Fluprostenol isopropyl ester |
A chiral enantiomer of 13,14-epoxy fluprostenol isopropyl ester whose phar… |
1 mg |
11169-1 |
More Info
|
13(R),14(R)-epoxy Fluprostenol isopropyl ester |
A chiral enantiomer of 13,14-epoxy fluprostenol isopropyl ester whose phar… |
10 mg |
11169-10 |
More Info
|
13(R),14(R)-epoxy Fluprostenol isopropyl ester |
A chiral enantiomer of 13,14-epoxy fluprostenol isopropyl ester whose phar… |
5 mg |
11169-5 |
More Info
|
17(R)-Resolvin D1 |
An aspirin-triggered epimer of RvD1; reduces human leukocyte transendothel… |
10 µg |
13060-10 |
More Info
|
17(R)-Resolvin D1 |
An aspirin-triggered epimer of RvD1; reduces human leukocyte transendothel… |
100 µg |
13060-100 |
More Info
|
17(R)-Resolvin D1 |
An aspirin-triggered epimer of RvD1; reduces human leukocyte transendothel… |
25 µg |
13060-25 |
More Info
|
17(R)-Resolvin D1 |
An aspirin-triggered epimer of RvD1; reduces human leukocyte transendothel… |
50 µg |
13060-50 |
More Info
|
17(R)-Resolvin D3 |
An aspirin-triggered epimer of resolvin D3; has been found in mouse inflam… |
10 µg |
9002880-10 |
More Info
|
17(R)-Resolvin D3 |
An aspirin-triggered epimer of resolvin D3; has been found in mouse inflam… |
100 µg |
9002880-100 |
More Info
|
17(R)-Resolvin D3 |
An aspirin-triggered epimer of resolvin D3; has been found in mouse inflam… |
25 µg |
9002880-25 |
More Info
|
17(R)-Resolvin D3 |
An aspirin-triggered epimer of resolvin D3; has been found in mouse inflam… |
50 µg |
9002880-50 |
More Info
|
17(R)-Resolvin D4 |
An aspirin-triggered epimer of RvD4 |
10 µg |
9002881-10 |
More Info
|
17(R)-Resolvin D4 |
An aspirin-triggered epimer of RvD4 |
100 µg |
9002881-100 |
More Info
|
17(R)-Resolvin D4 |
An aspirin-triggered epimer of RvD4 |
25 µg |
9002881-25 |
More Info
|
17(R)-Resolvin D4 |
An aspirin-triggered epimer of RvD4 |
50 µg |
9002881-50 |
More Info
|
17(R)-Resolvin D1-d5 |
An internal standard for the quantification of RvD1 by GC- or LC-MS |
10 µg |
11183-10 |
More Info
|
17(R)-Resolvin D1-d5 |
An internal standard for the quantification of RvD1 by GC- or LC-MS |
100 µg |
11183-100 |
More Info
|
17(R)-Resolvin D1-d5 |
An internal standard for the quantification of RvD1 by GC- or LC-MS |
25 µg |
11183-25 |
More Info
|
17(R)-Resolvin D1-d5 |
An internal standard for the quantification of RvD1 by GC- or LC-MS |
50 µg |
11183-50 |
More Info
|
17(R)-Resolvin D1 methyl ester |
A methyl ester version of 17(R)-RvD1 which may act as a lipophilic prodrug… |
10 µg |
9001072-10 |
More Info
|
17(R)-Resolvin D1 methyl ester |
A methyl ester version of 17(R)-RvD1 which may act as a lipophilic prodrug… |
100 µg |
9001072-100 |
More Info
|
17(R)-Resolvin D1 methyl ester |
A methyl ester version of 17(R)-RvD1 which may act as a lipophilic prodrug… |
25 µg |
9001072-25 |
More Info
|
17(R)-Resolvin D1 methyl ester |
A methyl ester version of 17(R)-RvD1 which may act as a lipophilic prodrug… |
50 µg |
9001072-50 |
More Info
|
(1R,3R)-3-Hydroxycyclopentane acetic acid methyl ester |
A synthetic intermediate useful for pharmaceutical synthesis. |
50 mg |
11384-50 |
More Info
|
(1R,3R)-3-Hydroxycyclopentane carboxylic acid benzyl ester |
A synthetic intermediate useful for pharmaceutical synthesis. |
50 mg |
11368-50 |
More Info
|
(1R,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester |
A synthetic intermediate useful for pharmaceutical synthesis. |
50 mg |
11372-50 |
More Info
|
(2R,6R)-Hydroxynorketamine (hydrochloride) |
An analytical reference standard that is categorized as an arylcyclohexyla… |
1 mg |
19603-1 |
More Info
|
(2R,6R)-Hydroxynorketamine (hydrochloride) |
An analytical reference standard that is categorized as an arylcyclohexyla… |
5 mg |
19603-5 |
More Info
|
15(R),19(R)-hydroxy Prostaglandin E1 |
19(R)-Hydroxylated prostaglandins occur in µg / ml concentrations in… |
100 µg |
13920-100 |
More Info
|
15(R),19(R)-hydroxy Prostaglandin E1 |
19(R)-Hydroxylated prostaglandins occur in µg / ml concentrations in… |
50 µg |
13920-50 |
More Info
|
15(R),19(R)-hydroxy Prostaglandin E1 |
19(R)-Hydroxylated prostaglandins occur in µg / ml concentrations in… |
500 µg |
13920-500 |
More Info
|
15(R),19(R)-hydroxy Prostaglandin F1α |
19(R)-Hydroxylated prostaglandins occur in µg / ml concentrations in… |
100 µg |
15920-100 |
More Info
|
15(R),19(R)-hydroxy Prostaglandin F1α |
19(R)-Hydroxylated prostaglandins occur in µg / ml concentrations in… |
50 µg |
15920-50 |
More Info
|
15(R),19(R)-hydroxy Prostaglandin F1α |
19(R)-Hydroxylated prostaglandins occur in µg / ml concentrations in… |
500 µg |
15920-500 |
More Info
|
15(R),19(R)-hydroxy Prostaglandin F2α |
19(R)-Hydroxylated PGs occur in µg / ml concentrations in the semen… |
100 µg |
16920-100 |
More Info
|
15(R),19(R)-hydroxy Prostaglandin F2α |
19(R)-Hydroxylated PGs occur in µg / ml concentrations in the semen… |
50 µg |
16920-50 |
More Info
|
15(R),19(R)-hydroxy Prostaglandin F2α |
19(R)-Hydroxylated PGs occur in µg / ml concentrations in the semen… |
500 µg |
16920-500 |
More Info
|
(1R,4R)-N-desmethyl Sertraline (hydrochloride) |
A metabolite of sertraline; has been found in wastewater effluent |
1 mg |
35741-1 |
More Info
|
(R)-Roscovitine |
A potent inhibitor of Cdk2 / cyclin E with an IC50 value of 0.1 µM;… |
1 mg |
10009569-1 |
More Info
|
(R)-Roscovitine |
A potent inhibitor of Cdk2 / cyclin E with an IC50 value of 0.1 µM;… |
10 mg |
10009569-10 |
More Info
|
(R)-Roscovitine |
A potent inhibitor of Cdk2 / cyclin E with an IC50 value of 0.1 µM;… |
5 mg |
10009569-5 |
More Info
|
(R)-Roscovitine |
A potent inhibitor of Cdk2 / cyclin E with an IC50 value of 0.1 µM;… |
500 µg |
10009569-500 |
More Info
|
(3R,5R)-Rosuvastatin (calcium salt) |
A potential impurity found in bulk preparations of rosuvastatin |
1 mg |
35381-1 |
More Info
|
(3R,5R)-Rosuvastatin (calcium salt) |
A potential impurity found in bulk preparations of rosuvastatin |
10 mg |
35381-10 |
More Info
|
(3R,5R)-Rosuvastatin (calcium salt) |
A potential impurity found in bulk preparations of rosuvastatin |
25 mg |
35381-25 |
More Info
|
(3R,5R)-Rosuvastatin (calcium salt) |
A potential impurity found in bulk preparations of rosuvastatin |
5 mg |
35381-5 |
More Info
|
RR-Src (trifluoroacetate salt) |
A synthetic peptide substrate; a substrate for EGF-mediated tyrosine phosp… |
1 mg |
33579-1 |
More Info
|
RR-Src (trifluoroacetate salt) |
A synthetic peptide substrate; a substrate for EGF-mediated tyrosine phosp… |
5 mg |
33579-5 |
More Info
|
RR-Src (trifluoroacetate salt) |
A synthetic peptide substrate; a substrate for EGF-mediated tyrosine phosp… |
500 µg |
33579-500 |
More Info
|